|
Article Excerpt
At least eight lawsuits have been filed against the makers of the blood-thinning drug Plavix, alleging that it has caused injury and death and that the manufacturers misled doctors and the public about its risks and effectiveness.
The drug was "touted as a 'super-aspirin' that would give a person even greater cardiovascular benefits than a much less expensive daily aspirin, while being safer and easier on a person's stomach than aspirin," according to a complaint filed in a New Jersey federal court. However, it alleges, "defendants knew or should have known that when taking Plavix, the risk of suffering a heart attack, stroke, internal bleeding, blood disorder, or death far outweigh any potential benefit." (LaBarre v. Bristol-Myers Squibb Co., No. 3:06-cv-06050 (D.N.J. filed Dec. 18, 2006).)
The plaintiff in that...
|
|
More articles from Trial
Texas court requires new look at fees when damages are reduced., March 01, 2007
Immigrants sue government over suspended benefits., March 01, 2007
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|
